$9.21
Live
Revenue is down for the last 3 quarters, 1.63B → 502.91M (in $), with an average decrease of 37.5% per quarter
Netprofit is up for the last 2 quarters, -691.17M → -100.34M (in $), with an average increase of 588.8% per quarter
2.17%
Downside
Day's Volatility :18.17%
Upside
16.35%
17.81%
Downside
52 Weeks Volatility :99.94%
Upside
99.93%
Period | Bright Health Group, Inc. | Sector (Financials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -83.09% | -10.1% | -6.7% |
6 Months | 1092.5% | -11.6% | -6.2% |
1 Year | 592.35% | -9.7% | -6.3% |
3 Years | -29.27% | 37.2% | 26.9% |
Market Capitalization | 93.6M |
Book Value | - $42.93 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -67.99 |
Wall Street Target Price | 126.67 |
Profit Margin | -56.18% |
Operating Margin TTM | -15.89% |
Return On Assets TTM | -5.01% |
Return On Equity TTM | -42.94% |
Revenue TTM | 2.6B |
Revenue Per Share TTM | 324.38 |
Quarterly Revenue Growth YOY | 23.3% |
Gross Profit TTM | 205.8M |
EBITDA | -358.6M |
Diluted Eps TTM | -67.99 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -33.48 |
EPS Estimate Next Year | -23.79 |
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Next Quarter | -0.07 |
What analysts predicted
Upside of 1275.35%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 130.6M | - |
Net Income | -62.6M | - |
Net Profit Margin | -47.95% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 280.7M | ↑ 114.86% |
Net Income | -125.3M | ↑ 100.09% |
Net Profit Margin | -44.66% | ↑ 3.29% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 330.15% |
Net Income | -248.4M | ↑ 98.22% |
Net Profit Margin | -20.58% | ↑ 24.08% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 4.0B | ↑ 233.75% |
Net Income | -1.2B | ↑ 374.3% |
Net Profit Margin | -29.24% | ↓ 8.66% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↓ 40.14% |
Net Income | -1.5B | ↑ 26.89% |
Net Profit Margin | -61.99% | ↓ 32.75% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 962.3M | ↓ 10.78% |
Net Income | -813.4M | ↑ 170.53% |
Net Profit Margin | -84.52% | ↓ 56.65% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.8B | ↑ 90.74% |
Net Income | -195.2M | ↓ 76.0% |
Net Profit Margin | -10.64% | ↑ 73.88% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↓ 14.11% |
Net Income | -274.7M | ↑ 40.69% |
Net Profit Margin | -17.42% | ↓ 6.78% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 3.53% |
Net Income | -315.8M | ↑ 14.96% |
Net Profit Margin | -19.34% | ↓ 1.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 551.4M | ↓ 66.22% |
Net Income | -691.2M | ↑ 118.9% |
Net Profit Margin | -125.34% | ↓ 106.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 502.9M | ↓ 8.8% |
Net Income | -100.3M | ↓ 85.48% |
Net Profit Margin | -19.95% | ↑ 105.39% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 820.4M | - |
Total Liabilities | 1.1B | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 120.73% |
Total Liabilities | 2.3B | ↑ 113.57% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 3.6B | ↑ 98.72% |
Total Liabilities | 2.3B | ↑ 0.45% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 4.7B | ↑ 29.64% |
Total Liabilities | 3.7B | ↑ 60.24% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 3.6B | ↑ 0.65% |
Total Liabilities | 2.3B | ↑ 41.94% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.3B | ↑ 46.6% |
Total Liabilities | 3.4B | ↑ 47.44% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.3B | ↓ 0.26% |
Total Liabilities | 3.7B | ↑ 6.98% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 4.6B | ↓ 12.33% |
Total Liabilities | 3.3B | ↓ 10.43% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 4.7B | ↑ 1.15% |
Total Liabilities | 3.7B | ↑ 13.42% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.8B | ↑ 3.92% |
Total Liabilities | 4.0B | ↑ 8.55% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -27.0M | - |
Investing Cash Flow | -6.9M | - |
Financing Cash Flow | 203.1M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.2M | ↓ 69.64% |
Investing Cash Flow | -94.6M | ↑ 1263.73% |
Financing Cash Flow | 424.1M | ↑ 108.84% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -57.2M | ↑ 597.34% |
Investing Cash Flow | -689.7M | ↑ 628.78% |
Financing Cash Flow | 712.4M | ↑ 68.0% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 82.1M | ↓ 243.36% |
Investing Cash Flow | -552.9M | ↓ 19.84% |
Financing Cash Flow | 1.0B | ↑ 46.49% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -238.0M | ↓ 9.86% |
Investing Cash Flow | 100.2M | ↓ 135.18% |
Financing Cash Flow | 155.8M | ↓ 13182.2% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 484.8M | ↓ 303.68% |
Investing Cash Flow | -633.1M | ↓ 731.64% |
Financing Cash Flow | 592.7M | ↑ 280.43% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 241.9M | ↓ 50.1% |
Investing Cash Flow | -318.5M | ↓ 49.7% |
Financing Cash Flow | -1.5M | ↓ 100.25% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -614.9M | ↓ 354.18% |
Investing Cash Flow | 488.4M | ↓ 253.37% |
Financing Cash Flow | 304.5M | ↓ 20684.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 234.5M | ↓ 138.14% |
Investing Cash Flow | -429.7M | ↓ 187.98% |
Financing Cash Flow | 1.1B | ↑ 250.26% |
Sell
Neutral
Buy
Bright Health Group, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Bright Health Group, Inc. | -8.84% | 1092.5% | 592.35% | -29.27% | -29.27% |
![]() Cigna Corp. | -4.24% | -25.78% | -9.02% | 23.22% | 40.84% |
![]() UnitedHealth Group Incorporated | -2.86% | -12.09% | -3.07% | 57.4% | 96.59% |
![]() CVS Health Corporation | -8.46% | -33.61% | -30.09% | 3.05% | 2.5% |
![]() Humana Inc. | -7.2% | -9.69% | 9.33% | 23.69% | 67.56% |
![]() Elevance Health, Inc | -5.59% | -16.33% | -5.75% | -5.75% | -5.75% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Bright Health Group, Inc. | NA | NA | NA | -33.48 | -0.43 | -0.05 | 0.0 | -42.93 |
![]() Cigna Corp. | 11.19 | 11.19 | 1.22 | 24.69 | 0.15 | 0.03 | 0.02 | 150.19 |
![]() UnitedHealth Group Incorporated | 22.03 | 22.03 | 1.66 | 23.29 | 0.25 | 0.07 | 0.01 | 87.25 |
![]() CVS Health Corporation | 22.47 | 22.47 | 1.36 | 8.61 | 0.05 | 0.04 | 0.04 | 55.81 |
![]() Humana Inc. | 20.12 | 20.12 | 1.28 | 28.36 | 0.19 | 0.06 | 0.01 | 132.67 |
![]() Elevance Health, Inc | 17.3 | 17.3 | 1.38 | 32.85 | 0.17 | 0.05 | 0.01 | 157.54 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Bright Health Group, Inc. | Sell | $93.6M | -29.27% | NA | -56.18% |
![]() Cigna Corp. | Buy | $72.2B | 40.84% | 11.19 | 3.69% |
![]() UnitedHealth Group Incorporated | Buy | $448.3B | 96.59% | 22.03 | 6.16% |
![]() CVS Health Corporation | Buy | $86.7B | 2.5% | 22.47 | 1.19% |
![]() Humana Inc. | Buy | $62.0B | 67.56% | 20.12 | 3.26% |
![]() Elevance Health, Inc | Buy | $105.7B | -5.75% | 17.3 | 3.87% |
Partners Group Holding AG Junk
State Street Corporation
Harbourvest Partners, LLC
Geode Capital Management, LLC
Renaissance Technologies Corp
Blackstone Inc
Bright Health Group, Inc.’s price-to-earnings ratio stands at None
Read MoreBright Health Group is built upon the belief that by aligning the best local resources in healthcare delivery with the financing of care, the company can drive a superior consumer experience, optimize clinical outcomes, reduce systemic waste and lower costs. Bright Health is a healthcare company that is building a national, integrated system of care, in close partnership with its Care Partners. Its differentiated approach is: Built on Alignment, Focused on the Consumer, and Powered by Technology. Bright Health have two market facing businesses: NeueHealth and Bright HealthCare. Through NeueHealth the company delivers high-quality virtual and in-person clinical care to nearly 75,000 unique patients through its 61 affiliated risk-bearing primary care clinics. Through Bright HealthCare the company offers Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets.
Organization | Bright Health Group, Inc. |
Employees | 2840 |
CEO | Mr. George Lawrence Mikan III |
Industry | Financial |
Tompkins Financial Corp
$53.99
-0.48%
Western Asset High Income Fund II Inc
$4.49
+0.45%
Blackrock Corporate High Yield Fund Inc
$8.51
+0.24%
James River Group Holdings Ltd
$19.86
-1.54%
Pacific Premier Bancorp Inc
$19.42
-1.67%
D Wave Quantum Inc
$1.37
-17.95%
BNYM HIGH YIELD STRAT
$2.15
-0.46%
Berkshire Hills Bancorp Inc
$21.31
-1.16%
BLACK MOUNTAIN ACQUISITION-A
$10.55
+0.19%